Skip to main content
Journal of the International Association of Providers of AIDS Care logoLink to Journal of the International Association of Providers of AIDS Care
. 2019 Jan 15;18:2325958218821961. doi: 10.1177/2325958218821961

Conflicting Views in Narratives on HIV Transmission via Medical Care

Michael A Vance 1,
PMCID: PMC6748459  PMID: 30798671

Abstract

Molecular studies suggest that HIV arose in Africa between 1880 and 1940. During this period, there were campaigns by European colonial governments that involved unsterile injections of large numbers of Africans. That, along with other unsafe therapeutic interventions, may have propelled the evolution of HIV from SIV. Since subtype B in Africa may have been concentrated in white African homosexuals, it is possible that Westerners rather than Haitians introduced the virus to the New World. Amplification of HIV subtype B took place in Haiti, where transmission was facilitated by hazardous medical procedures including plasmapheresis. Representations in the media, however, largely ignore Western contributions to the spread of AIDS. This article focuses on the value of alternative narratives in fostering a balanced view that is less stigmatizing on developing nations.

Keywords: Africa, AIDS, colonialism, Cuba, Haiti, HIV, HIV subtype B, iatrogenic


What Do We Already Know about This Topic?

We know that HIV arose in Africa and that in the early phases of the pandemic medical interventions contributed to its spread.

How Does Your Research Contribute to the Field?

This article highlights evidence that the spread of HIV may differ from that which is commonly accepted.

What Are Your Research’s Implications toward Theory, Practice, or Policy?

The alternatives presented here will help diminish stigma associated with AIDS in some populations as well as encourage improved infection control measures.

Introduction

According to the World Health Organization, around 35 million people have died of AIDS and nearly 1 in 25 adults in sub-Saharan Africa are currently infected with HIV, the virus that causes AIDS.1 Phylogenetic studies and other research on HIV/AIDS have generated histories on the origins of the pandemic. Such narratives, formulated by experts, inform policy and impact the lives of people throughout the world.

Genetic polymorphisms in infectious agents between populations demonstrates relatedness but determining the exact routes of evolution in time and space entails speculation. For a given set of circumstances (outcome), there may exist more than one potential pathway leading to that outcome. Acknowledging this uncertainty is especially important in a delicate matter such as a disease associated with sexuality, drug use, and poverty. HIV-positive victims among the economically disadvantaged have few advocates in the socially rarified world of biomedical science. It is critical to appreciate the potential negative impact on HIV-infected peoples of some of these narratives, such as perpetuating stereotypes of sexual promiscuity.2

The focus of this essay is the value of alternatives to 2 dominant narratives on HIV and AIDS: That Haiti was responsible for bringing HIV from Africa to the West and that injections and other invasive medical procedures have a negligible contribution to the spread of AIDS.

Transmission of HIV

HIV passes from person to person by exchange of body fluids, which can occur iatrogenically and through nonmedical activities (Table 1). Because of differing environments and customs, including sexual practices, and dissimilarities in biology of HIV strains and human populations, HIV transmission varies geographically. Pattern 1 designates a “concentrated epidemic” in which HIV circulates in a limited subpopulation engaged in risky behavior, while pattern 2 is “generalized,” in which most victims are not identified with a high-risk subpopulaton.3 Pattern 1, which predominates in North America, Australia, and Western Europe, is spread by intravenous drug abuse and needle sharing and men having sex with men. With pattern 2, in sub-Saharan Africa and much of the Caribbean, heterosexual transmission is a major mode of infection.

Table 1.

Medical and Nonmedical Transmission of HIV.

  • I. Iatrogenic transmission

    1. Blood and blood product transfusions and related activities

    2. Injections

    3. Other invasive procedures: surgery, dialysis, dental work, colonoscopy, and so on

  • II. Nonmedical transmission

    1. Intravenous drug abuse

    2. Homosexual relations

    3. Heterosexual relations

    4. Vertical transmission (mother to child in utero or breastfeeding)

    5. Tattoos, body piercing, scarifications, genital mutilation, and so on

Clarifying the underlying mechanisms for these patterns is a bit awkward. In the United States, for instance, the sexual revolution of the 1960s included heterosexuals, but heterosexual transmission there was low.

The prevalence of HIV infection in black Africa is staggeringly high (Figure 1), too high, it would seem, to be explained simply by transmission through heterosexual relations. Since it is widely persecuted and often illegal in sub-Saharan Africa, homosexual relations are probably more widespread than reported and hidden homosexual transmission might be misclassified as heterosexual. As an explanation for high prevalence of AIDS in Africa that doesn’t hold because in pattern 1, there is a preponderance of men with HIV while in African’s pattern 2 more females are infected than males. HIV passage between gay men involves anal intercourse and the prevalence of this practice among heterosexual Africans, because it is stigmatized, may also be underappreciated.4,5 If unprotected male–female anal intercourse is common, that would be an alternative explanation more consistent with observed sex ratios—especially considering that men who have sex with men are often married to women.5 It is also possible, but far from certain, that dry sex (drying and tightening of the vagina for sex, a common practice in some communities) enhances HIV transmission.6 Additionally, iatrogenic transmission, which would affect women more than men because they undergo more invasive procedures, may contribute to HIV burden in Africa.7

Figure 1.

Figure 1.

Millions of persons infected in different geographic regions (USAIDS World AIDS Day Report, 2010): Sub-Saharan Africa, South and Southeastern Asia, Western Europe, Eastern Europe and Central Asia, Latin America, and North America.

Origin of AIDS

Although some have suggested a non-African origin,8 a persuasive argument has been made that the M group of HIV-1, the only HIV that has spread around the world, originated from SIVcpz, the SIV from chimpanzees in Central Africa.9 HIV-2, an immunosuppressive retrovirus endemic in Western Africa, is derived from SIVsmm that infects another primate, the sooty mangabey, in that region.9 Genetic analysis not only localizes the origin HIV-1M to Central Africa but also suggests that all HIV-1M traces back to a single SIVcpz and molecular clock studies, based upon the divergence of HIV-1 and SIV nucleic acid sequences, indicate that the jump to humans was recent with estimates ranging from 1880 to 1940.10-12

Over time, HIV-1M traveled to different locations where it evolved separately to form different branches of the phylogenetic tree—the different subtypes, or clades, of HIV-1M. In North America, South America, the Caribbean, Western Europe, and Australia, subtype B dominates over all others (Figure 2A-C). In sub-Saharan Africa, the most prevalent subtype of HIV-1M is C. Each of the major subtypes are present in Africa and Kinshasa, a Congo city considered an early focal point for the spread of HIV, not surprisingly, has all major subtypes circulating.11 It is curious, however, that subtype B, though relatively uncommon in Africa, came to dominate in so many regions outside that continent (Figure 2A).

Figure 2.

Figure 2.

From Los Alamos National Laboratory, HIV sequence database (http://www.hiv.lanl.gov/components/sequence/HIV/geo/geo.comp). The frequency of HIV-1M subtypes by geographic areas according to the HIV sequence database. Subtypes with 2 letters refer to those derived from recombination of subtypes. A, Distribution of HIV-1M subtypes: World. B, Distribution of HIV-1M subtypes: Africa. C, Distribution of HIV-1M subtypes: Caribbean.

Hunters who kill and butcher monkeys for bush meat mix simian blood (and other fluids) with their own and passage of SIV to humans in these circumstances is probable.13 SIVcpz infection of a hunter in the Central African range of infected chimpanzees is suspected to be the source of what was to become HIV-1M. But people have been hunting, butchering, and otherwise interacting with SIV-infected primates for millennia. What was different in the 20th century that allowed SIV to evolve in Africa and HIV to arise and create the AIDS pandemic?

One theory is that oral polio vaccine used in Central Africa in the 1950s and 1960s was contaminated with SIV due to alleged use of chimpanzee kidney cells in vaccine preparation.14 Millions of persons were injected, after all, with polio vaccine that had been tainted with a different virus, simian virus 40. Aside from the fact that the oral polio vaccination occurred too late—by the 1950s, AIDS was in Central Africa11,15,16—the supporting evidence is not strong.16 One reviewer of the polio theory stated,

I asked several AIDS researchers where they thought HIV came from. Just about all of them said they thought it was an old African disease that emerged from the bush when the winds of change blew through the continent—that HIV was driven by urbanization, war, trucking, mining and prostitution.17(p17)

A massive increase in population was part of an explosion of social changes that transformed Africa with the arrival of the European colonial period at the end of the 1800s.18,19 It is possible that population growth alone was sufficient for HIV to emerge in Africa, but other factors have worked synergistically to unleash AIDS: urbanization with infrastructure improvements paradoxically facilitating greater mobility and dissemination of disease,19 breakdown of traditional society, transmission by sex workers,20 untreated genital ulcers,21 lack of circumcision in men,22 other sexually transmitted diseases,23 and so on.

Iatrogenesis and AIDS

In 18 months starting in 1917, French physician Eugene Jamot treated 5347 cases of African trypanosomiasis (sleeping sickness) with injections of atoxyl, a toxic arsenical, using 6 syringes.7,24,25 The subcutaneous atoxyl was often combined with intravenous therapy with either tartar emetic or tryparsamide.24 At the time, it was appreciated that patients occasionally contracted hepatitis after injections, but given the obliviousness to other dangers, it is near certain that adequate sterilization of needles and syringes did not occur.25

The first 1 to 2 months of an HIV infection is characterized by a high level of viremia and if SIV partially adopted to humans behaves similarly, that would create a “perfect storm” for the serial passage of SIV to ultimately produce a virus adapted to humans. The injections were given weekly for 12 weeks, so that a patient infected early could contaminate the syringes used for several weeks thereafter, when virus levels in the blood are high.

Animal infection with simian–human immunodeficiency virus (SHIV) supports the injection hypothesis. The SHIV, an engineered virus, did not cause illness in the monkeys infected nor was it transmissible to other monkeys in the colony. But serial passage in macaques, through intravenous injection and bone marrow transplant, generated a virulent virus that caused an immunodeficiency disease that passed from monkey to monkey.26,27

A single campaign using inadequately sterilized injection equipment in Central Africa seems insufficient to account for the emergence of HIV/AIDS. The question is, therefore, whether unsafe injections, transfusions, and medical procedures were commonplace during the critical period of the late 1800s and first half of the 1900s. The answer is a resounding “yes,” to the extent that Drucker et al25 labeled the era the “century of the injection” (Table 2). The smallpox campaign involved intradermal injections but that does not necessarily imply low risk. Due to lack of refrigeration in hot climate, the vaccinia virus was maintained in chains of humans—pus from one vaccinated person to vaccinated others who, in turn, donated their pus for more vaccines.28

Table 2.

Major Colonial Era Undertakings with Potential for Iatrogenic Transmission of Blood-Borne Viruses in Central Africa. Disease Treatments All Involved Injections.

Dates Project References
1893-1910 Up to 35 000 smallpox arm-to-arm vaccinations 25
1920-1935 Massive French anti-sleeping sickness campaign with from 60 000 to 600 000 injections per year 24,28
1930s-1950s Campaigns undertaken against yaws, syphilis, kala-azar, and leprosy 24,30
Late 1940s-1954 Tens or hundreds of thousands of injections yearly in Leopoldville STD clinics. Many received injections prophylactically or with misdiagnosed as having STDs 24,33
1950s-1970s Large-scale polio, yellow fever, and smallpox vaccinations. After 1960, oral polio vaccine took the place of injections 30
1940s forward Widespread use of transfusions to treat anemia of malaria, pregnancy, sickle cell, and other diseases 29

There have been at least 2 books7,24 and numerous articles25,29-32 assembling a reasoned argument that injections, transfusions, and other medical procedures introduced by colonial powers facilitated the emergence of AIDS. Once established, unsafe medical procedures may have accelerated virus expansion.32,33

The injection theory of the genesis of HIV is impossible to discard. Yet it has been easy to overlook, sometimes escaping significant mention even in works that fault colonialism for establishing conditions favoring the diffusion of AIDS.8,34,35 Schneider and Drucker said,

It is remarkable that despite so much evidence of the wide use of blood transfusions during the decades before the emergence of HIV in sub-Saharan Africa, there is almost a total absence of discussion of these millions of transfusions for the beginning of the AIDS epidemic in Africa…European countries were eager to introduce the new techniques developed during World War II to demonstrate the value of Western technology that accompanied colonial rule.29(p992-993)

The same eagerness holds for the modern hypodermic syringe itself, though it was perfected independently in 1853 by Alexander Wood and Gabriel Pravaz. By the later 1800s, the syringe had become wildly popular in the West. Its use for intravenous injection of narcotic analgesics created legions of addicts but that apparently didn’t dampen the enthusiasm of colonists to use this new technology (Table 2).

As to why AIDS is so astonishingly common in sub-Saharan Africa (Figure 1), many explanations have been proffered. Several factors likely operated simultaneously to facilitate the transmission of HIV in sub-Saharan Africa and their interactions may not be straightforward. Controlled trials demonstrate that male circumcision, for example, has a protective effect against sexual transmission of HIV,36 but encouraging it could be counterproductive if operations are performed with unsterilized instruments.

Prominent is the “concurrency hypothesis” that AIDS is prevalent in Africa because Africans, allegedly more so than other peoples, carry on simultaneous relationships with more than one sexual partner.34,37,38 That this type of heterosexual networking is driving the AIDS epidemic is now sometimes stated as fact even though there are observations that cast doubt on it.39,40

Early in the AIDS pandemic official sources stated that iatrogenesis was an important driver of HIV infection in sub-Saharan Africa. The later turnaround, discounting medical spread and blaming sexual transmission nearly exclusively, seems grounded in proof by forceful repetition. Duh’s description of health care in sub-Saharan Africa suggests a potential for underestimating iatrogenic transmission.

There is a widespread belief in many African countries that injected medication is more effective than oral medication. Patients (or parents of pediatric patients) tend to be disappointed when a clinic issues oral medication instead of an injection. Some people even request an injection if it is not offered…. The use of injections in many African countries is not limited to clinics and hospitals. Private individuals, particularly in rural areas, may keep some medication and injection equipment in their homes to give injections to town folks. In some cases, people giving injections are inadequately trained in aseptic techniques.

I visited a rather large clinic in a big city in Africa in December 1987. In a conversation with one of the clinic doctors, she remarked that the doctors in the country were fully aware of the potential danger of reusing disposable needles, ‘but we cannot, we simply cannot afford to throw needles and syringes away’.41(p1856)

Assertions that iatrogenic AIDS is rare in sub-Saharan Africa based upon computer modeling are disconcerting for several reasons. Estimates of the probability of infection from injection with contaminated equipment have been based, in part, on data from accidental needle sticks which may underestimate risk, since in such cases the plunger is not depressed.42 Reuse of needles and syringes may be concealed and therefore underrepresented in the models,43,44 the prevalence of injections by untrained providers is likewise underappreciated along with the demand for injections41,43 and iatrogenic spread through transfusions and invasive procedures.45,46 Medical transmission of HIV is misclassified as heterosexual spread when the risk of the latter is exaggerated due to a variety of reasons, including not taking into consideration the decrease in frequency of coitus with at-risk partners that accompanies concurrency,47 and an assumption that seroconversion is always due to sexual transmission.

Contracting HIV is more likely in Africa simply because a greater percentage of the population is HIV positive, increasing the likelihood that a sexual encounter or dirty syringe includes the virus. Beyond that, access to antiretroviral drugs is less, which means that blood and secretions are more infective and prophylactic use in at-risk persons is limited. Infectivity of HIV in the West is not necessarily the same as African strains of HIV are different and Africans, with poorer nutrition and chronic diseases like schistosomiasis and malaria, may be more vulnerable to infection. Estimates of the efficacy of HIV transmission through injections from experience with Western populations do not reliably reflect the situation in other cultures. It is not improbable, based on the reality of health care in resource poor countries, that medical transmission of HIV is substantial, at least in some localities.48

Haiti

In 2007, the popular press announced that scientists had demonstrated that HIV-1 subtype B was first carried by Haitians from Africa to Haiti, from where it spread to the rest of the world.49 The reports were based on a study of HIV genomic sequences from Haitians and patients from other countries to find that the oldest, non-African HIV subtype B was in Haiti, “the most parsimonious explanation for this pattern is that all those subtype B infections across the world emanated from a single founder event linked to Haiti.”50(p1856) The article generated objections from Haitians, who felt unfairly blamed, and rebuttals from scientists in agreement.51 While the Haiti to US spread seems probable,52 to assert it with certainty dismisses viable alternatives.

It is not impossible that North Americans or Western Europeans carried subtype B to their home country where conditions for its propagation were lacking. Westerners could then have brought the disease to Haiti, through sexual tourism or other route, and if circumstances were favorable, amplification could have occurred there while the original HIV subtype B met a dead end in the Western country.

Conditions in Haiti were indeed favorable for amplification of HIV infection whether introduced from Africa or the West. Hemo-Caribbean was open for 20 months in 1971 and 1972 in Port-au-Prince, the capital of Haiti. It was a center for plasmapheresis where desperately poor Haitians sold their plasma for a few dollars.24 Foreign businesses in turn purchased the plasma for production of antibodies, clotting factors, and other products; at its peak, some 6000 L/mo were shipped to American pharmaceutical companies.53,54 The formed elements were reinfused in the Haitian donor so that, unlike blood donations, a person could sell plasma several times a month. The operation paid inadequate attention to the safety of the donors and to screening of plasma for diseases53 and, combined with the deficiency in sterile supplies and techniques characteristic of health-care delivery in impoverished lands, that would create another “perfect storm” for HIV spread.

There are issues with that alternative scenario. Subsequent phylogenetic studies of HIV are consistent with an earlier Caribbean epidemic.55 Using viral RNA recovered from Haitian and US patients in the 1970s, Worobey et al55 estimated a growth rate of HIV as rapid or more rapid in the United States compared to Haiti. That suggests that conditions in the United States, at least in the gay community, were favorable to the propagation of HIV. Sex tourism flourished in Haiti in the late 1970s but was less in the 1960s, the decade when HIV seems to have been introduced into the New World. Thousands of Haitian workers were sent to Zaire, the newly liberated Belgian Congo, after its independence in 1960, so there was great opportunity for them to bring the virus back home.

The peculiar distribution of HIV-1 subtypes in South Africa, however, is consistent with primary spread to the West and secondary transport to Haiti.

South Africa

As in other sub-Saharan countries, HIV-1 subtype B is uncommon in South Africa. In 1997, van Harmelen et al56 reported, however, that of 26 homosexuals with HIV infection, 25 had subtype B while only 4 of 32 heterosexuals did. More telling, the homosexual group was 62% white and had no blacks while heterosexuals were 66% black and 9% white. A larger South African study, limited to men who have sex with men, subsequently confirmed that white men were usually infected with subtype B and black men almost always with subtype C.57 Though AIDS has hit South Africa very hard, it was a latecomer, with the first 2 cases described in the literature in 1983.58 They were both homosexual flight attendants who presented with full-blown AIDS, including diarrhea and weight loss. Given the lag time to symptoms in HIV infection, they probably acquired HIV in the early 1970s. Both had traveled to the United States and Europe.

While it is sometimes assumed that gay white Africans contracted HIV from sexual contact with European or American men, an alternative infection source helps explain the unusual B subtype global distribution. Subtype B evolved separately in Africa among a privileged, jet-setting, homosexual, largely white population. Sexual encounters of this group with Europeans and North Americans were common, facilitating a spread to these continents prior to the Caribbean.59 Although infected Westerners brought HIV with them wherever they went, it was only when it was introduced to Haiti, primed by poverty for iatrogenic spread, that the disease took off.

Cuba

The epidemiology of HIV in Cuba is strikingly different from Haiti and the rest of the Caribbean and the Americas. This Cuban anomaly bears on how HIV disseminated.

In most Caribbean countries, HIV-1 subtype B infections dwarfs the others but in Cuba subtype B represents a small fraction of HIV infections and, as in Central Africa, a wide variety of HIV-1 subtypes are represented (Figure 2C). This is predictable. From the revolution of 1959 until after the fall of the Soviet Union in 1991, Cuba military and civilian personnel were stationed in or near HIV-afflicted countries in Africa while persons from these countries spent long periods studying and training in Cuba. There was also considerable exchange between Cuba and Eastern Europe, but that area is believed to have been relatively free of AIDS until the 1990s.

Despite repeated introduction of the retrovirus into Cuba, as demonstrated by the diversity of HIV strains, the prevalence of infection there is radically lower than other countries in the region (Figure 3). The rarity of HIV/AIDS in Cuba has been credited to its policy of forced quarantining HIV-positive individuals and its aggressive screening, treatment, and follow-up of cases. These policies, however, could not be instituted until a blood test was available to Cuba in 1986. By rights, AIDS should have by then been a devastating plague in Cuba as it was in Haiti. There is something about Cuba that was operational before HIV testing that prevented AIDS from gaining a foothold (Table 3).

Figure 3.

Figure 3.

Estimated percentages of population with HIV in Caribbean countries and the United States. Percentages calculated from people living with AIDS in the UNAIDS 2010 Global Report (http://www.unaids.org/globalreport/Global_report.htm) divided estimated population in 2010.

Table 3.

Conditions in Cuba That Favor and Conditions That Deter HIV Transmission.

Conditions that Favor Conditions that Deter
  • Concurrent multiple partners

  • Commercial sex workers (but less common early in the revolution)

  • Men not circumcised

  • Much international travel and exchange with countries with high prevalence of HIV infection

  • Little intravenous drug abuse

  • Condoms now widely accepted (but perhaps not before public health condom campaign in response to AIDS threat)

  • Public well educated about AIDS

  • Government quarantined the HIV positive (in past)

  • Women perhaps more empowered in Cuba

  • Health care in Cuba discourages iatrogenic transmission

If the medical system of Cuba were of the standard of other poor countries, it is unlikely that AIDS would be uncommon. Cuban medicine is delivered by highly trained professionals who are cognizant of the importance of aseptic technique. The low prevalence of HIV in Cuba reflects a powerful effect of controlling iatrogenic spread.

Conclusion

Many times in Italy I laughed, hearing the Italians speak of the French disease, and the French call it the disease of Naples; and in truth both would have had the name better if they had called it the disease of the Indies.60(p72)

This famous quote concerning syphilis illustrates a universal human attribute of, blaming the other, especially in things sexual. Why AIDS suddenly surfaced in the 20th century is not, and likely will never be, known with certainty, but it is natural that the medical establishment would be reluctant to recognize medicine’s possible contribution. Hence, the ready acceptance of Africans’ sexuality as the driver of the AIDS epidemic.

Sexual transmission is important in spreading AIDS in Africa,38,61,62 but that does not mean it is the only driver and infection should not automatically be attributed to promiscuity or concurrent relations. There are factors other than promiscuity that facilitate conversion to HIV-positive status: untreated sexually transmitted infections and genital ulcers, lack of male circumcision, female genital mutilation, underuse of condoms, women not empowered to resist unprotected relations, men isolated from women by labor demands fomenting high-risk prostitution, and potential misrepresentation of iatrogenic HIV infection as sexual.30,63-67

The emergence of AIDS provides lessons that can be useful. One is that unthinking enthusiasm for new technology carries unanticipated risks,30 a lesson familiar to those versed in the history of pharmacotherapy. Another should be humility. That well-intentioned medical services rendered to African countries possibly created the AIDS pandemic should give us pause.

Reasoned arguments against a large role for medical transmission have been presented.61,62,68,69 Genotyping of HIV RNA indicates that, in one area of South Africa, sexual liaisons with older men explain the high rate of infections in young women.70 South Africa has the highest prevalence of HIV, yet its health care system is recognized as one of the continent’s best, suggesting that the contribution of iatrogenic transmission is modest. There are too many contradictory observations, however, to be disregarded: unexplained HIV-positive youngsters born of HIV-negative women, widespread use of unsterile needles, equipment, and transfusions; and the history of large outbreaks of nosocomial HIV infections under circumstances resembling those in Africa.43,71-78

War and political instability, characteristic of contemporary Africa, compromise controls over the quality of professional medical care and that provided by traditional practitioners. In resource-limited countries, this disruption can lead to outbreaks of iatrogenic infection. Such was the case in the 1980s in Romania, where many children in orphanages became HIV positive because of unsafe medical injections.75

A leading medical journal editorialized, “Although interest in how the outbreak originated may be a matter of scientific curiosity for the future, apportioning blame for the outbreak now is neither fair to people working to improve a dire situation, nor helpful in combating the disease.”79(p813)

That was not to defend Africans or Haitians being scapegoated for AIDS. It objected that the United Nations was held responsible—accurately, it turns out—for having introduced cholera to Haiti in the wake of the 2010 earthquake.

The possibility that modern medicine, a pride of industrialized societies, has been instrumental in spreading the AIDS pandemic is inherently onerous to decedents of colonialists. More than that, it conflicts with the preferred narrative: Colonialism was bad, but it did bring benefits like Western-style health care with hospitals and clinics that cure terrible diseases and eradicated or nearly eradicated smallpox, polio, and Guinea worm. It is more reassuring to implicate Africans and Haitians who do not have the sway of the United Nations.80

Ioannidis emphasized, in a highly cited article, that published research findings are frequently erroneous.81 Among his corollaries is that the hotter the field of research, the greater the likelihood that findings are false. Recognition of uncertainty is particularly important in the red-hot research area of AIDS. The real reason that AIDS is so prevalent in sub-Saharan Africa, and indeed some populations within the United States,82 is poverty and disenfranchisement.

In a communication that was forcefully disputed,83 Gisselquist asserted,

The hypothesis that HIV-positive wives are almost certainly infected via sex threatens millions of women with disgrace, divorce, loss of access to their children, and bodily harm. An alternative message—that HIV infections are not a reliable sign of sexual behavior—is not only mandated by the evidence, but also protects women and families.84(p659)

With regional differences in sexual and medical practices (not to mention biology), it is risky to definitively implicate one or the other as the driver of HIV infection for a single locale much less than for sub-Saharan Africa as a whole. The inability of mathematical models to account for dramatic changes of HIV infection rates in some African countries illustrates this.85 Recognizing uncertainty in our narratives promotes open-mindedness and minimizes stigmatization. In the present example, dismissing iatrogenic transmission of HIV not only harms women but also unnecessarily labels people as promiscuous.

Footnotes

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iD: Michael A. Vance, PhD Inline graphic https://orcid.org/0000-0001-9779-6372

References

  • 1. World Health Organization. Global Health Observatory (GHO) Data: HIV/AIDS. 2017. http://www.who.int/gho/hiv/en/ (accessed 20 December 2018).
  • 2. Schoepf BG. AIDS, history, and struggles over meaning In: Kalipeni E, Craddock S, Oppong JR, Ghjosh J, eds. HIV and AIDS in Africa: Beyond Epidemiology. Malden, MA: Blackwell; 2004. [Google Scholar]
  • 3. Wilson D, Challa S. HIV epidemiology: recent trends and lessons In: Seifman RM, David AC, Lule EL, eds. The Changing HIV/AIDS Landscape. Washington, DC: World Bank; 2009:9–28. [Google Scholar]
  • 4. Halpern DT. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks. Part I. AIDS Patient Care STDs. 1999;13(12):717–730. [DOI] [PubMed] [Google Scholar]
  • 5. Smith AD, Tapsoba P, Pesu N, Sanders EJ, Jaffe HW. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet. 2009;374(9687):416–422. [DOI] [PubMed] [Google Scholar]
  • 6. Hilber AM, Francis SC, Chersich M, et al. Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS One. 2010;5(2):e9119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Gisselquist D. Points to Consider: Responses to HIV/AIDS in Africa, Asia and the Caribbean. London, England: Adonis & Abbey; 2008. [Google Scholar]
  • 8. Katner HP, Pankey GA. Evidence for a Euro-American origin of human immunodeficiency virus (HIV). J Nat Med Assoc. 1987;79(10):1069–1072. [PMC free article] [PubMed] [Google Scholar]
  • 9. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harbor Perspect Med. 2011;1(1):a006841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Korber B, Muldoon M, Theiler J, et al. Timing the ancestor of the HIV-1 pandemic strains. Science. 2000;288(5472):1789–1796. [DOI] [PubMed] [Google Scholar]
  • 11. Worobey M, Gemmel M, Teuwen DE, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature. 2008;455(7213):661–664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Tebit DM, Arts EJ. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis. 2011;11(1):45–55. [DOI] [PubMed] [Google Scholar]
  • 13. Kalish ML, Wolfe ND, Ndongmo CB, et al. Central African hunters exposed to simian immunodeficiency virus. Emerg Infect Dis. 2005;11(12):1928–1930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Hooper E. The River: A Journey to the Source of HIV and AIDS. Boston, MA: Little, Brown & Company; 1999. [Google Scholar]
  • 15. Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications from the origin of the epidemic. Nature. 1998;391(6667):594–597. [DOI] [PubMed] [Google Scholar]
  • 16. Molez JF. The historical question of acquired immunodeficiency syndrome in the 1960s in the Congo River basin in relation to cryptococcal infection. Am J Trop Med Hyg. 1998;58(3):273–276. [DOI] [PubMed] [Google Scholar]
  • 17. Epstein H. Something happened. N Y Rev Books. 1999;14:16–18. [Google Scholar]
  • 18. Basset MT, Mhloyi M. Women and AIDS in Zimbabwe: the making of an epidemic. Int J Health Serv. 1991;21(1):143–156. [DOI] [PubMed] [Google Scholar]
  • 19. Iliffe J. The African AIDS Epidemic: A History. Athens, OH: Ohio University Press; 2006. [Google Scholar]
  • 20. Talbott JR. Size matters: the number of prostitutes and the global HIV/AIDS pandemic. PLoS One. 2007;2(6):e543 doi:101371/journal.pone.0000543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. de Sousa JD, Muller V, Lemey P, Vandamme AM. High GUD incidence in the early 20th century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains. PLoS ONE. 2010;5(4):e9936 doi:10.1371/journal.pone.0009936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Caldwell JC, Caldwell P. The African AIDS epidemic. Sci Am. 1996;274(3):62–68. [DOI] [PubMed] [Google Scholar]
  • 23. Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Topics HIV Med. 2004;12(4):104–107. [PubMed] [Google Scholar]
  • 24. Pepin J. The Origins of AIDS. Cambridge, MA: Cambridge University Press; 2011. [Google Scholar]
  • 25. Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet. 2001;358(9297):1989–1992. [DOI] [PubMed] [Google Scholar]
  • 26. Joag SV, Li Z, Foresman L, et al. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol. 1996;70(5):3189–3197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Joag SV, Adany I, Li Z, et al. Animal model of mucosaly transmitted human immunodeficiency virus type I disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS in pig-tailed macaque. J Virol. 1997;71(5):4016–4023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Chitnis A, Rawls D, Moore J. Origin of HIV type 1 in colonial French Equatorial Africa? AIDS Res Hum Retroviruses. 2000;16(1):5–8. [DOI] [PubMed] [Google Scholar]
  • 29. Schneider WH, Drucker E. Blood transfusions in the early years of AIDS in sub-Saharan Africa. Am J Public Health. 2006;96(6):984–994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Pepin J, Labbe AC. Noble goals, unforeseen consequences: control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses. Trop Med Int Health. 2008;13(6):744–753. [DOI] [PubMed] [Google Scholar]
  • 31. Marx PA, Alcabes PG, Drucker E. Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of human immunodeficiency virus in Africa. Phil Trans R Soc Lond B. 2001;356(1410):911–920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Hogan CA, Iles J, Frost EH, et al. Epidemic history and iatrogenic transmission of blood-borne viruses in mid-20th century Kinshasa. J Infect Dis. 2016;214(3):353–360. [DOI] [PubMed] [Google Scholar]
  • 33. Pepin J. The expansion of HIV-1 in colonial Leopoldville, 1950s: driven by STDs or STD control? Sex Transm Infect. 2012;88(4):283–286. [DOI] [PubMed] [Google Scholar]
  • 34. Timberg C, Halperin D. Tinderbox: How the West Sparked the AIDS Epidemic and How the World Can Finally Overcome It. New York, NY: Penguin; 2012. [Google Scholar]
  • 35. Uzodinma I. Our Kind of People: A Continent’s Challenge. A Country’s Hope. New York, NY: Harper; 2012. [Google Scholar]
  • 36. Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009. ;(2):CD003362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Epstein H. The Invisible Cure: Africa, the West and the Fight Against AIDS. New York, NY: Farrar, Straus & Giroux; 2007. [Google Scholar]
  • 38. Mah TL, Shelton JD. Concurrency revisited: increasing and compelling epidemiological evidence. J Int AIDS Soc. 2011;14:33 doi:10.1186/1758-2652-14-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Kertzschmar M, White RG, Carael M. Concurrency is more complex than it seems. AIDS. 2010;24(2):313–315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Sawers L, Stillwaggon E. Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidence. J Int AIDS Soc. 2010;13:34 doi:10.1186/1758-2652-13-34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Duh SV. Blacks and Aids: Causes and Origins. Newbury Park, CA: Sage; 1991. [Google Scholar]
  • 42. Haui AM, Armstrong GL, Hutin YJF. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004;15(1):7–16. [DOI] [PubMed] [Google Scholar]
  • 43. Okwen MP, Ngem BY, Alomba FA, Capo MV, Reid SR, Ewang EC. Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: validation of a survey instrument that probes for specific misconceptions. Harm Reduct J. 2011;8:4 doi:10.1186/1477-7517-8-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Reid S. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J. 2009;6:24 doi:10.1186/1477-7517-6-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Mishra V, Khan S, Liu L, Kottiri B. Medical Injection Use and HIV in Sub-Saharan Africa. DHS Comparative Reports No. 21. Calverton, MA: Macro International; 2008. [Google Scholar]
  • 46. Fleming AF. HIV and blood transfusion in sub-Saharan Africa. Transfus Sci. 1997;18(2):167–179. [DOI] [PubMed] [Google Scholar]
  • 47. Sawers L. Measuring and modelling concurrency. J Int AIDS Soc. 2013;16:17431 doi:10.7448/IAS.16.1.17431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Gisselquist D. Denialism undermines AIDS prevention in sub-Saharan Africa. Int J STD AIDS. 2008;19(10):649–655. [DOI] [PubMed] [Google Scholar]
  • 49. Chong JR. Analysis clarifies route of AIDS. Los Angeles Times. 2007. [Google Scholar]
  • 50. Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M. The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci. 2007;104(47):18566–18570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Pape JW, Farmer P, Koenig S, Fitzgerald D, Wright P, Johnson W. The epidemiology of AIDS in Haiti refutes the claims of Gilbert et al. Proc Natl Acad Sci U S A. 2008;105(10):E13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Junqueira DM, Almeida SE. HIV-1 subtype B: traces of a pandemic. Virology. 2016;495:173–184. [DOI] [PubMed] [Google Scholar]
  • 53. Severo R. Impoverished Haitians sell plasma for use in the U.S. New York Times. 28 January 1972. [Google Scholar]
  • 54. Hahn P. The vampire of the Caribbean. Open Salon. 2011. https://web.archive.org/web/20120502110232/http://open.salon.com/blog/xylocopa/2011/11/29/the_vampire_of_the_caribbean (accessed 20 December 2018).
  • 55. Worobey M, Watts TD, McKay RA, et al. 1970s and ‘Patient 0’ HIV-1 genome illustrates early HIV/AIDS history in North America. Nature. 2016;539(7627):98–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS. 1997;11(1):81–87. [DOI] [PubMed] [Google Scholar]
  • 57. Middelkoop K, Rademeyer C, Brown BB, et al. Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa. Acquir Immune Defic Syndr. 2014;65(4):473–480. [DOI] [PubMed] [Google Scholar]
  • 58. Ras GJ, Simson IW, Anderson R, Prozesky OW, Hamersma T. Acquired immunodeficiency syndrome: a report of 2 South African cases. S Afr Med J. 1983;64(4):140–142. [PubMed] [Google Scholar]
  • 59. Seth R. HIV infection in South Africa, 1982–1988: a review. S Afr Med J. 1989;76(7):314–318. [PubMed] [Google Scholar]
  • 60. Zinsser H. Rats, Lice and History. New York, NY: Blue Ribbon; 1934. [Google Scholar]
  • 61. Schmid GP, Buve A, Mugyeni P, et al. Transmission of HIV-1 infections in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet. 2004;363(9407):482–488. [DOI] [PubMed] [Google Scholar]
  • 62. Walker PR, Worobey M, Rambaut A, Holmes EC, Pybus OG. Sexual transmission of HIV in Africa. Nature. 2003;422(6933):679. [DOI] [PubMed] [Google Scholar]
  • 63. Zulu EM, Dodoo FNA, Ezeh AC. Urbanization, poverty, and sex: roots of risky sexual behaviors in slum settlements in Nairobi, Kenya In: Kalipeni E, Craddock S, Oppong JR, Ghosh J, eds. HIV and AIDS in Africa: Beyond Epidemiology. Malden, MA: Blackwell; 2009:167–174. [Google Scholar]
  • 64. Hunter DJ. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention. Epidemiology. 1993;4(1):63–72. [PubMed] [Google Scholar]
  • 65. Heimer CA. Old inequalities, new diseases: HIV/AIDS in sub-Saharan Africa. Annu Rev Sociol. 2007;33:551–577. [Google Scholar]
  • 66. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Maxmen A. Social cycle aids HIV spread. Nature. 2016;535:335.27443718 [Google Scholar]
  • 68. White RG, Cooper SB, Kedhar A, et al. Quantifying HIV-1 transmission due to contaminated injections. Proc Natl Acad Sci U S A. 2007;104(23):9794–9799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. French K, Riley S, Garnett G. Simulations of the HIV epidemic in sub-Saharan Africa: sexual transmission versus transmission through unsafe medical injections. Sex Transm Dis. 2006;33(3):127–134. [DOI] [PubMed] [Google Scholar]
  • 70. de Oliveira T, Kharsany BM, Graff T, et al. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. Lancet HIV. 2017;4(1):e41–e51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Hiemstra R, Rabie H, Schaaf SH, et al. Unexplained HIV-1 infection in children – documenting cases and assessing for possible risk factors. S Afr Med J. 2004;94(3):188–193. [PubMed] [Google Scholar]
  • 72. Okinyi M, Brewer DD, Potterat JJ. Horizontally-acquired HIV infection in Kenyan and Swazi children. Int J STD AIDS. 2009;20(12):852–857. [DOI] [PubMed] [Google Scholar]
  • 73. World Health Organization. Injection Practices in the Developing World – Results and Recommendations from Field Studies in Uganda and Indonesia. EDM Research Series No. 020 Geneva, Switzerland: World Health Organization; 1996. [Google Scholar]
  • 74. Greenberg AE, Nguyen-Dinh P, Mann JM, et al. The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. JAMA. 1991;259(4):545–549. [PubMed] [Google Scholar]
  • 75. Hersh BS, Popovici F, Jezek Z, et al. Risk factors for HIV infection among abandoned Romanian children. AIDS. 1993;7(12):1617–1624. [DOI] [PubMed] [Google Scholar]
  • 76. Velandia M, Fridkin SK, Cardenas V, et al. Transmission of HIV in dialysis centre. Lancet. 1995;345(8962):1417–1422. [DOI] [PubMed] [Google Scholar]
  • 77. Yerly S, Quadri R, Negro F, et al. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis. 2001;184(3):369–372. [DOI] [PubMed] [Google Scholar]
  • 78. Gokhale RH, Galang RR, Pitman JP, et al. A tale of 2 HIV outbreaks caused by unsafe injections in Cambodia and the United States, 2014–2015. Am J Infect Control. 2017;45(2):106–107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Anon. As cholera returns to Haiti, blame is unhelpful. Lancet Infect Dis. 2010;10:813. [DOI] [PubMed] [Google Scholar]
  • 80. Farmer P. AIDS and Accusation: Haiti and the Geography of Blame. Berkeley, CA and Los Angeles, CA: University of California Press; 2006. [Google Scholar]
  • 81. Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2(8);e124 doi:10.1371/journal.pmed.0020124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Cohen J. The sunshine state’s dark cloud. Science. 2018;360(6394):1176–1179. [DOI] [PubMed] [Google Scholar]
  • 83. Mills EJ, Ford N. Authors’ reply to HIV status in serodiscordant couples. Lancet Infect Dis. 2011;11:659. [DOI] [PubMed] [Google Scholar]
  • 84. Gisselquist D. HIV status in serodiscordant couples. Lancet Infect Dis. 2011;11(9):658–659. [DOI] [PubMed] [Google Scholar]
  • 85. Nagelkerke NJ, Arora P, Jha P, Williams B, McKinnon L, de Vlas SJ. The rise and fall of HIV in high-prevalence countries: a challenge for mathematical modeling. PLoS Comput Biol. 2014;10(3):e1003459 doi:10.1371/journal.pcbi.1003459. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the International Association of Providers of AIDS Care are provided here courtesy of SAGE Publications

RESOURCES